Today: 9 June 2026
Denison Mines stock today: DNN ends 2025 slightly higher as uranium holds near $82
1 January 2026
1 min read

Denison Mines stock today: DNN ends 2025 slightly higher as uranium holds near $82

NEW YORK, January 1, 2026, 07:08 ET — Market closed.

  • Denison Mines closed Wednesday up about 1% at $2.66, ahead of the New Year’s Day U.S. market holiday.
  • Uranium ended Dec. 31 at $81.65 a pound; prices were up nearly 7% over the past month, Trading Economics data showed.
  • Traders head into Friday’s reopening watching uranium prices, nuclear-fuel supply-chain headlines, and Denison’s next corporate update.

Denison Mines Corp shares rose about 1% to $2.66 in the last U.S. trading session of 2025, with markets closed on Thursday for New Year’s Day.

That modest move still matters in uranium-linked stocks because investors finished the year with the spot uranium price holding above $80 a pound, keeping the sector sensitive to commodity signals and nuclear policy headlines.

Denison is a developer rather than a producer, so its shares often act as a proxy for long-term uranium prices and project progress, not near-term cash flow.

Uranium ended Dec. 31 at $81.65 per pound, down 0.24% on the day but up 6.87% over the past month, Trading Economics data showed. The same source’s model implied uranium near $83.91 per pound by the end of the quarter.

In the futures market, the front-month UxC uranium contract was around $81.85 per pound, CME Group quotes showed.

Nuclear fuel-chain headlines were also in focus. Urenco USA said it completed an initial production run enriching uranium to 8.5% U-235 and plans to begin commercial production of LEU+ — uranium enriched between 5% and 10% — in mid-2026, while expanding capacity measured in SWU (separative work units) by 2027. “We are the only domestic supplier of enriched uranium,” said Jeremy Derryberry, Urenco USA’s director of communications. Midland Reporter-Telegram

Denison, based in Canada, focuses on uranium exploration and development in Saskatchewan’s Athabasca Basin. It holds a 95% interest in the Wheeler River project, which hosts the Phoenix and Gryphon deposits, and also owns stakes in the McClean Lake joint venture and other exploration assets, a Reuters company profile shows.

At Wheeler River, Denison has outlined plans for Phoenix using in-situ recovery (ISR), a method that circulates a mining solution through underground ore and pumps uranium-bearing fluid back to the surface for processing.

The setup leaves Denison’s stock especially reactive to uranium-price momentum, shifts in risk appetite for smaller miners, and signs that the nuclear build-out is translating into tighter fuel-cycle capacity and contracting.

Investors in the group also keep an eye on larger uranium names such as Cameco and other North American-focused miners for market signals on contracting activity, even when smaller developers have no fresh company-specific news.

Before the next session on Friday, chart watchers will likely key off the stock’s position within its 52-week range of $1.08 to $3.42, according to Investing.com data.

Denison’s investor calendar lists reporting dates through its third-quarter 2025 results and notes dates are subject to change; it does not yet show a reporting date for the next quarter.

Stock Market Today

  • ASX Penny Stocks to Watch: Boss Energy, Michael Hill, Tribeca Global Natural Resources
    June 8, 2026, 10:46 PM EDT. Australian penny stocks Boss Energy (ASX:BOE), Michael Hill International (ASX:MHJ), and Tribeca Global Natural Resources offer potential value amid mixed performances. Boss Energy, a pre-revenue uranium explorer, shows a market cap around A$529 million with growing losses but remains debt-free and undervalued by 51.5%. Michael Hill International, a jewelry retailer with A$127 million market cap, generated A$656 million revenue, with earnings up 664% last year despite a large one-off loss. Tribeca Global Natural Resources, an investment firm valued at A$206 million, focuses on infrastructure securities. Investors should note management inexperience at Boss and Michael Hill, alongside recent volatility. These stocks present opportunities for risk-tolerant investors seeking exposure in ASX small caps amid global market and geopolitical uncertainty.

Latest articles

Chip Rally Breaks as Nasdaq Faces Tight Labor Market

Nasdaq rises after hours as chips recover

9 June 2026
Nasdaq jumped 0.86% as chip stocks rebounded, with Intel soaring 11.2% on news Google ordered over 3 million AI chips for 2028, while Apple slid 1.9% after unveiling new AI features. Investors await Wednesday’s May CPI inflation report, which could spark volatility in tech and growth stocks.
Broadcom Stock Rebounds, AI Remains an Open Question for Wall Street

Broadcom Stock Rebounds, AI Remains an Open Question for Wall Street

9 June 2026
Broadcom shares jumped 2.8% to $396.60 as chip stocks rebounded after last week’s $1 trillion sector wipeout, but investors remain cautious after Broadcom’s Q2 revenue missed expectations and the company declined to raise its 2027 AI revenue forecast, fueling concerns that rapid AI growth may not meet Wall Street’s high demands.
BitMine Stock Gains as Ether Holdings Approach 5% Target

BitMine Stock Gains as Ether Holdings Approach 5% Target

9 June 2026
BitMine Immersion Technologies shares jumped 6% after revealing ether holdings climbed to 5.54 million tokens, now 4.59% of Ethereum’s supply, with $9.6 billion in crypto, cash and stakes. The company priced a $273.8 million preferred stock offering, with proceeds possibly funding more ETH purchases and staking. BitMine projects $230 million in annualized staking revenues but warns of risks if ETH or financing falters.
Mingteng Stock Jumps 81% After Halting $100M Share Sale Plan

Mingteng Stock Jumps 81% After Halting $100M Share Sale Plan

9 June 2026
Mingteng International shares soared 81.3% to $1.94 after the company ended its at-the-market stock sale plan, having raised about $20.6 million in gross proceeds; trading volume hit 24.2 million, dwarfing its $12 million market value, as the move outpaced gains in other U.S.-listed China auto stocks.
Outlook Therapeutics stock drops after FDA issues another Lytenava CRL for wet AMD
Previous Story

Outlook Therapeutics stock drops after FDA issues another Lytenava CRL for wet AMD

Apple stock slips into 2026 as year-end tech pullback bites; AAPL earnings next
Next Story

Apple stock slips into 2026 as year-end tech pullback bites; AAPL earnings next

Go toTop